Pryce G - Search Results

1

COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.

Baker D, Roberts CAK, Pryce G, Kang AS, Marta M, Reyes S, Schmierer K, Giovannoni G, Amor S. Baker D, et al. Among authors: pryce g. Clin Exp Immunol. 2020 Nov;202(2):149-161. doi: 10.1111/cei.13495. Epub 2020 Aug 1. Clin Exp Immunol. 2020. PMID: 32671831 Free PMC article. Review.

2

Endocannabinoids control spasticity in a multiple sclerosis model.

Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Makriyannis A, Khanolkar A, Layward L, Fezza F, Bisogno T, Di Marzo V. Baker D, et al. Among authors: pryce g. FASEB J. 2001 Feb;15(2):300-2. doi: 10.1096/fj.00-0399fje. Epub 2000 Dec 8. FASEB J. 2001. PMID: 11156943

3

The therapeutic potential of cannabis in multiple sclerosis.

Baker D, Pryce G. Baker D, et al. Among authors: pryce g. Expert Opin Investig Drugs. 2003 Apr;12(4):561-7. doi: 10.1517/13543784.12.4.561. Expert Opin Investig Drugs. 2003. PMID: 12665412 Review.

4

Mifepristone or inhibition of 11beta-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Delta(9)-tetrahydrocannabinol in mice.

Pryce G, Giovannoni G, Baker D. Pryce G, et al. Neurosci Lett. 2003 May 1;341(2):164-6. doi: 10.1016/s0304-3940(03)00159-9. Neurosci Lett. 2003. PMID: 12686391

5

Quantification of neurodegeneration by measurement of brain-specific proteins.

Petzold A, Baker D, Pryce G, Keir G, Thompson EJ, Giovannoni G. Petzold A, et al. Among authors: pryce g. J Neuroimmunol. 2003 May;138(1-2):45-8. doi: 10.1016/s0165-5728(03)00092-4. J Neuroimmunol. 2003. PMID: 12742652 Free article.

6

The therapeutic potential of cannabis.

Baker D, Pryce G, Giovannoni G, Thompson AJ. Baker D, et al. Among authors: pryce g. Lancet Neurol. 2003 May;2(5):291-8. doi: 10.1016/s1474-4422(03)00381-8. Lancet Neurol. 2003. PMID: 12849183 Review.

7

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.

Pryce G, Ahmed Z, Hankey DJ, Jackson SJ, Croxford JL, Pocock JM, Ledent C, Petzold A, Thompson AJ, Giovannoni G, Cuzner ML, Baker D. Pryce G, et al. Brain. 2003 Oct;126(Pt 10):2191-202. doi: 10.1093/brain/awg224. Epub 2003 Jul 22. Brain. 2003. PMID: 12876144

8

Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction.

Harry R, Gegg M, Hankey D, Zambarakji H, Pryce G, Baker D, Calder V, Adamson P, Greenwood J. Harry R, et al. Among authors: pryce g. J Immunol. 2005 Feb 15;174(4):2327-2335. doi: 10.4049/jimmunol.174.4.2327. J Immunol. 2005. PMID: 15699169 Free PMC article.

9

Emerging properties of cannabinoid medicines in management of multiple sclerosis.

Pryce G, Baker D. Pryce G, et al. Trends Neurosci. 2005 May;28(5):272-6. doi: 10.1016/j.tins.2005.03.006. Trends Neurosci. 2005. PMID: 15866202 Review.

10

Cannabinoids and neuroprotection in CNS inflammatory disease.

Jackson SJ, Diemel LT, Pryce G, Baker D. Jackson SJ, et al. Among authors: pryce g. J Neurol Sci. 2005 Jun 15;233(1-2):21-5. doi: 10.1016/j.jns.2005.03.002. J Neurol Sci. 2005. PMID: 15894331 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page